BACKGROUND Radium-223 prolongs overall survival in patients with castration-resistant prostate cancer (CRPC) and symptomatic bone metastases, regardless of prior docetaxel. Whether or not chemotherapy can be safely administered following radium-223 treatment is of clinical importance. An exploratory analysis of prospectively collected data, from the ALSYMPCA (ALpharadin in SYMptomatic Prostate ...

Marie Curie gave outstanding contributions to science and society that were recognized still in her lifetime. In particular, the discovery of radium completely changed the therapeutic methods for treatment of cancer and other diseases, and allowed the development of radiotherapy and nuclear medicine. Radium was also used in many non-medical applications. Radium applications fostered the growth ...

BACKGROUND Myelosuppression is common in patients with progressive castration-resistant prostate cancer and bone metastases. Radium-223 prolongs overall survival in these patients but may cause myelosuppression; understanding risk factors will improve clinical decision making. We describe hematologic safety of radium-223 in ALSYMPCA and post hoc analyses identifying patients at increased risk f...

IN THE years 1903 and 1904, shortly after the discovery of radium, small amounts of radioactivity were discovered in the water of the health springs of the spas of Germany and France. It was found that this radioactivity was due to radon, a gaseous daughter-product of radium. The supposed medicinal benefit from drinking of, or bathing in natural springwater was ascribed to the radon. A medical ...

BACKGROUND Radium-223 dichloride, or radium-223, is a first-in-class alpha emitter that selectively targets bone metastases with high-energy, short-range alpha particles and is approved for the treatment of patients with castration-resistant prostate cancer (CRPC), symptomatic bone metastases, and no known visceral metastatic disease. Nurses are essential in educating patients about radium-223....

Four isotopes of radium with different half-lives exist in nature. In aquatic systems, radium isotopes present distinct characteristics in salt water and fresh water environments. In fresh waters, radium appears adsorbed to particulate material while in sea water radium presents a conservative behavior, being the concentration of different isotopes of radium governed by the processes of dilutio...

BACKGROUND Radium-223 dichloride (radium-223), an alpha emitter, selectively targets bone metastases with alpha particles. We assessed the efficacy and safety of radium-223 as compared with placebo, in addition to the best standard of care, in men with castration-resistant prostate cancer and bone metastases. METHODS In our phase 3, randomized, double-blind, placebo-controlled study, we rando...

In the present investigation, soil samples were collected from 10 villages belonging to Pathankot district, Punjab, India and assessed for radium content using LR-115 plastic detector. The ‘track etch’ technique has been employed for measuring the radium content. From the radium content, radon exhalation rates and mass exhalation rates were calculated for these samples. The mass exhalation rate...

BACKGROUND Bone metastases are associated with increased morbidity and poor prognosis in breast cancer patients. Radium-223 dichloride is a calcium mimetic that localizes to bone, providing targeted therapy for skeletal metastasis. METHODS We investigated the mode of action of radium-223 dichloride using breast cancer cell, osteoclast, and osteoblast cultures as well as a mouse model of breas...

BACKGROUND The treatment of metastatic castration-resistant prostate cancer has changed with the introduction of radium-223, cabazitaxel, abiraterone and enzalutamide. To assess value for money, their cost effectiveness in patients with metastatic castration-resistant prostate cancer previously treated with docetaxel from the Dutch societal perspective was investigated. METHODS A cost-effecti...